Treatment for the procoagulant state in type 2 diabetes

被引：30

作者：

Colwell, JA

机构：

[1] Med Univ S Carolina, Ctr Diabet, Charleston, SC 29425 USA

[2] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA

来源：

ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA | 2001年 / 30卷 / 04期

关键词：

D O I：

10.1016/S0889-8529(05)70225-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This article discusses the procoagulent state in type 2 diabetes mellitus. There are alterations of the intrinsic coagulation system, fibrinolysis, and platelet function, which contribute to a prothrombotic state in many people with diabetes. Therapeutic approaches are presented, including a rationale for intensive glycemic regulation and aspirin therapy for diabetic individuals who are at high vascular risk.

引用

收藏

页码：1011 / +

页数：21

相关论文

共 84 条

[31] Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension:: principal results of the hypertension optimal treatment (HOT) randomised trial [J].

Hansson, L ;

Zanchetti, A ;

Carruthers, SG ;

Dahlöf, B ;

Elmfeldt, D ;

Julius, S ;

Ménard, J ;

Rahn, KH ;

Wedel, H ;

Westerling, S .

LANCET, 1998, 351 (9118) :1755-1762

[32] FINAL REPORT ON THE ASPIRIN COMPONENT OF THE ONGOING PHYSICIANS HEALTH STUDY [J].

HENNEKENS, CH .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (03) :129-135

[33] REDUCTION OF PLATELET-AGGREGATION INDUCED BY EUGLYCEMIC INSULIN CLAMP [J].

HIRAMATSU, K ;

NOZAKI, H ;

ARIMORI, S .

DIABETOLOGIA, 1987, 30 (05) :310-313

[34] HEMOSTATIC ALTERATIONS WITH EXERCISE CONDITIONING IN NIDDM [J].

HORNSBY, WG ;

BOGGESS, KA ;

LYONS, TJ ;

BARNWELL, WH ;

LAZARCHICK, J ;

COLWELL, JA .

DIABETES CARE, 1990, 13 (02) :87-92

[35] Improved glycemic control and lipid profile and normalized fibrinolytic activity on a low-glycemic index diet in type 2 diabetic patients [J].

Järvi, AE ;

Karlström, BE ;

Granfeldt, YE ;

Bjorck, IE ;

Asp, NGL ;

Vessby, BOH .

DIABETES CARE, 1999, 22 (01) :10-18

[36] Gemfibrozil treatment of hypertriglyceridemia: Improvement on fibrinolysis without change of insulin resistance [J].

Jeng, JR ;

Jeng, CY ;

Sheu, WHH ;

Lee, MMS ;

Huang, SH ;

Shieh, SM .

AMERICAN HEART JOURNAL, 1997, 134 (03) :565-571

[37] RELEASE OF PLATELET PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN WHOLE-BLOOD IS INCREASED IN PATIENTS WITH TYPE-II DIABETES [J].

JOKI, R ;

KLEIN, RL ;

LOPESVIRELLA, MF ;

COLWELL, JA .

DIABETES CARE, 1995, 18 (08) :1150-1155

[38] PLATELET PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN PATIENTS WITH TYPE-II DIABETES [J].

JOKL, R ;

LAIMINS, M ;

KLEIN, RL ;

LYONS, TJ ;

LOPESVIRELLA, MF ;

COLWELL, JA .

DIABETES CARE, 1994, 17 (08) :818-823

[39]

Jokl R, 1997, DIABETES METAB REV, V5, P1

[40]

Jokl R, 1997, INT TXB DIABETES MEL, P1543

← 1 2 3 4 5 6 7 8 9 →